DR. STEVEN GLENN CLARK M.D NPI 1053408476

NPI Details

DR. Steven Glenn Clark, M.D is an internal medicine in Cleveland, MS with 29 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. DR. Steven Glenn Clark, M.D NPI is 1053408476. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE
Graduation Year:1997

The provider's business location address is:

810 E SUNFLOWER RD
CLEVELAND, MS
ZIP 38732-800
Phone: (662) 843-3606

The NPI 1053408476 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, denosumab, 1 mg (HCPCS:J0897)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only (HCPCS:93010)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, basic group of blood chemicals (calcium, ionized) (HCPCS:80047)
• Automated urinalysis test (HCPCS:81003)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Liver function blood test panel (HCPCS:80076)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Hemoglobin a1c level (HCPCS:83036)
• Natriuretic peptide (heart and blood vessel protein) level (HCPCS:83880)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• X-ray of chest, 2 views (HCPCS:71046)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)
• Vitamin d-3 level (HCPCS:82306)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron binding capacity (HCPCS:83550)
• Iron level (HCPCS:83540)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Critical care, first 30-74 minutes (HCPCS:99291)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Magnesium level (HCPCS:83735)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose (HCPCS:J7321)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Injection, lincomycin hcl, up to 300 mg (HCPCS:J2010)
• Coagulation function measurement, d-dimer; quantitative (HCPCS:85379)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Advance care planning, first 30 minutes (HCPCS:99497)
• Folic acid level, serum (HCPCS:82746)
• Albumin (protein) level (HCPCS:82040)
• Blood test, clotting time (HCPCS:85610)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Follow-up nursing facility visit per day, typically 15 minutes (HCPCS:99308)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• X-ray of abdomen, 1 view (HCPCS:74018)
• Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Uric acid level, blood (HCPCS:84550)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Detection test by nucleic acid for multiple types influenza virus (HCPCS:87502)
• Ultrasound of both sides of head and neck blood flow (HCPCS:93880)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Nursing facility discharge day management, 30 minutes or less (HCPCS:99315)
• Amylase (enzyme) level (HCPCS:82150)
• Lipase (fat enzyme) level (HCPCS:83690)
• X-ray of knee, 3 views (HCPCS:73562)
• Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
• X-ray of shoulder, 1 view (HCPCS:73020)
• Follow-up nursing facility visit per day, typically 25 minutes (HCPCS:99309)
• Injection, lidocaine hcl for intravenous infusion, 10 mg (HCPCS:J2001)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Troponin (protein) analysis, quantitative (HCPCS:84484)
• Ultrasound of leg arteries or artery grafts (HCPCS:93925)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza (HCPCS:87428)
• Urine microalbumin (protein) analysis (HCPCS:82044)
• Removal of impacted ear wax (HCPCS:69210)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Initial nursing facility visit per day, typically 35 minutes (HCPCS:99305)
• Hospital observation care on day of discharge (HCPCS:99217)
• X-ray of upper spine, 2-3 views (HCPCS:72040)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use (HCPCS:90677)
• Complete ultrasound scan behind abdominal cavity (HCPCS:76770)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
• Initial hospital observation care per day, typically 30 minutes (HCPCS:99218)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• X-ray of foot, 2 views (HCPCS:73620)
• X-ray of knee, 1-2 views (HCPCS:73560)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Initial nursing facility visit per day, typically 45 minutes (HCPCS:99306)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Ultrasound scan of head and neck soft tissue (HCPCS:76536)
• X-ray of chest, 1 view (HCPCS:71045)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Hospital observation or inpatient care admitted and discharged on the same day for low severity problem, typically 40 minutes (HCPCS:99234)
• Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm (HCPCS:17263)
• Limited ultrasound scan of abdomen (HCPCS:76705)
• Ultrasound study of arm or leg veins with compression and maneuvers (HCPCS:93970)
• Creatine kinase (cardiac enzyme) level, mb fraction only (HCPCS:82553)
• X-ray of ankle, minimum of 3 views (HCPCS:73610)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Phosphate level (HCPCS:84100)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 10/6/2006 and was last updated on 11/5/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: